InsidersTradesSigma
Explore the complete record of transactions filed by Madan Ajay, Directeur du Développement. Insider active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 5 filings have been logged. Total volume traded: €417k. The latest transaction was disclosed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Ajay Madan is the Chief Development Officer at Crinetics Pharmaceuticals, Inc. He is responsible for product development strategy and innovation within the company.